A method of swing on a swing is disclosed, in which a user positioned on a standard swing suspended by two chains from a substantially horizontal tree branch induces side to side motion by pulling alternately on one chain and then the other.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7135197 | Stable pharmaceutical composition useful for treating gastrointestinal disorders The present invention provides a pharmaceutical composition comprising at least one pharmaceutically acceptable bismuth-containing compound, at least one pharmaceutically acceptable non-clay-derived suspending agent, and water. The suspension exhibits reduced upward... | 11/14/2006 |
| 6790462 | Calcium dietary supplement A dietary supplement composition contains phosphorus and from greater than 1.3 to less than 2.2 parts by weight calcium per part by weight phosphorus, and may, optionally, further contain Vitamin D, Vitamin B12, folate and Vitamin B6, provides ... | 09/14/2004 |
| 6767559 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present invention admixe... | 07/27/2004 |
| 6743827 | Method for preparing colloidal solution of bismuth sodium tartrate A method for preparation of a semitransparent colloidal solution of bismuth sodium tartrate generally comprises producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from the aqueous solution at a pH of approximately... | 06/01/2004 |
| 6716884 | Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof A pharmaceutical composition for the administration of phloroglucinol includes phloroglucinol in combination with a buffer system capable of buffering the composition when placed in an aqueous medium to a pH between 3 and 7. ... | 04/06/2004 |
| 6699912 | Method for preparing colloidal solution of bismuth sodium tartrate A method for preparation of a semitransparent colloidal solution of bismuth sodium tartrate generally comprises producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from the aqueous solution at a pH of ap... | 03/02/2004 |
| 6589507 | Foaming antacid suspension tablets The invention relates to antacid preparations comprising the following constituents: (i) an acid-binding active constituent (antacid) or a mixture of such active constituents, (ii) an effervescent mixture that releases CO2, (iii) a polymeric surfact... | 07/08/2003 |
| 6515008 | Formulation The present invention is directed to a novel pharmaceutical composition of polymorph B which has been found to be stable and palatable for long term commercial usage.... | 02/04/2003 |
| 6489317 | Method for eradication of Helicobacter pylori The invention provides methods for the treatment and/or prevention of recurrence of a gastrointestinal disorder associated with Helicobacter pylori in a patient requiring said treatment and/or prevention, which comprise administering to the patient a ther... | 12/03/2002 |
| 6482865 | Method for preparing colloidal solution of bismuth sodium tartrate A method for preparation of a semitransparent colloidal solution of bismuth sodium tartrate generally comprises producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from the aqueous solution at a pH of ap... | 11/19/2002 |
| 6444232 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 09/03/2002 |
| 6436447 | Evacuant Disclosed is an evacuant possessing a sufficient evacuating effect in a small dose substantially without accompanying any irritation to bowel, irrespective of whether its preparations are in the form of tablets, liquids or elixirs, and having a suppressin... | 08/20/2002 |
| 6420435 | Method for treating gastrointestinal disorders Methods of treating gastrointestinal disorders (e.g. heart bum, GERD, and gastric indigestion) comprising orally administering therapeutically effective amounts of limonene are described herein.... | 07/16/2002 |
| 6248760 | Tablet giving rapid release of nicotine for transmucosal administration A tablet for the transmucosal administration of nicotine. The nicotine is in one or more layers upon a non-nicotine containing matrix. The nicotine layers rapidly dissolve in the mouth. The nicotine is then rapidly absorbed by the intra-oral mucosal surfa... | 06/19/2001 |
| 6201012 | Composition for controlling parasites The present invention relates to a composition for controlling parasites, in and on animals, which comprises, as active ingredient, a combination, in variable proportions, of at least one parasiticidally active compound, in free form or in salt form, sele... | 03/13/2001 |
| 6197329 | Anti-nausea compositions and methods The present disclosure is directed to novel nutritional anti-nausea compositions, anti-emetic compositions, and methods of using same. The compositions provide improved relief from nausea and/or vomiting. The compositions are particularly useful for pregn... | 03/06/2001 |
| 6110506 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 08/29/2000 |
| 6110505 | Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate The invention provides an essentially translucent liquid antacid composition with dihydroxyaluminum sodium carbonate (DASC) as the active ingredient. The DASC is prepared by co-drying DASC with a polyol, and the resulting co-dried DASC/polyol is mixed wit... | 08/29/2000 |
| 6103274 | Pharmaceutical, orally applicable composition A pharmaceutical, orally applicable composition is disclosed, whereby the composition contains at least one antacid active substance as well as more than 45% by weight of a sugar and/or sugar alcohol and between 12% and 35% by weight of water. The composi... | 08/15/2000 |
| 6048552 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 04/11/2000 |
| 6037380 | Ultra-fine microcrystalline cellulose compositions and process Ultra-fine microcrystalline cellulose compositions are disclosed which produce highly stable suspensions and/or dispersions in which substantially all of the microcrystalline cellulose has a particle size not greater than about 0.7 μm. The compositions i... | 03/14/2000 |
| 5976578 | Liquid antacid compositions Liquid antacid compositions containing a tri- or di-ester buffer have a reduced final product pH providing for a more efficacious preservative system and better tasting product without compromising to acid neutralization capacity of the antacid.... | 11/02/1999 |
| 5939091 | Method for making fast-melt tablets A process for making a fast melt tablet and a powdered material is disclosed. The process includes providing a powdered material with a density of from 0.2 to about 0.55 grams and precompacting the material to increase the density prior to compacting the ... | 08/17/1999 |
| 5914135 | Liquid antacid compositions Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior resistance to microbial attack and enhanced taste properties.... | 06/22/1999 |
| 5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole A method for treatment of gastric acid related diseases by inhibition of gastric acid secretion comprising administering to a mammal in need of treatment a therapeutically effective amount of the (-)-enantiomer of 5-methoxy-2-(4-methoxy-3,5-dimethyl-2... | 03/02/1999 |
| 5871781 | Apparatus for making rapidly-dissolving dosage units The present invention involves an apparatus for making comestible units. The comestible units made in accordance with the present invention can include active ingredients and are capable of dissolving in the mouth of the consumer within several seconds. T... | 02/16/1999 |
| 5858413 | Antacid composition, substantially free of preservatives A pharmaceutical, oral composition of a liquid to semisolid consistency is disclosed, wherein the composition, substantially free of preservatives, contains at least one antacid active substance as well as more than 45% by weight, a sugar and/or sugar alc... | 01/12/1999 |
| 5843466 | Coolant compositions Coolant compositions, flavorant compositions and ingestible and topical compositions containing at least one coolant compound selected from monomenthyl succinate, alkali metal salts of monomenthyl succinate, alkaline earth metal salts of monomenthyl succi... | 12/01/1998 |
| 5807577 | Fast-melt tablet and method of making same There is provided an improved, fast-melting solid dosage form which readily disintegrates when placed in the mouth. The solid dosage form preferably being a tablet comprising the following primary ingredients whose proportions are calculated as weight per... | 09/15/1998 |
| 5807578 | Fast-melt tablet and method of making same Provided is an improved, fast-melting solid dosage form which readily disintegrates when placed in the mouth. The solid dosage form preferably being a tablet comprising the following primary ingredients whose proportions are calculated as weight percent o... | 09/15/1998 |
| 5807580 | Film coated tablet compositions having enhanced disintegration characteristics A pharmaceutical composition for oral administration comprising a film coated tablet exhibiting enhanced disintegration characteristics, said film coating comprising a hydrophilic film forming polymer such as hydroxypropyl methylcellulose and an alkaline ... | 09/15/1998 |
| 5725865 | Coolant compositions Coolant compositions, flavorant compositions and ingestible and topical compositions containing at least one coolant compound selected from monomenthyl succinate, alkali metal salts of monomenthyl succinate, alkaline earth metal salts of monomenthyl succi... | 03/10/1998 |
| 5681827 | Composition and method for treatment of gastrointestinal distress An aqueous pourable liquid composition is disclosed comprising at least 8% sodium alginate and potassium bicarbonate for use in the treatment of gastrointestinal distress.... | 10/28/1997 |
| 5629013 | Chewable calcium carbonate antacid tablet compositions Chewable antacid tablet compositions comprising calcium carbonate sweetened with aspartame, and preferably also saccharin wherein said composition is in a solid unit dose form to be ingested by chewing.... | 05/13/1997 |
| 5622719 | Process and apparatus for making rapidly dissolving dosage units and product therefrom The present invention is a method of preparing rapidly dissolving comestible units such as tablets. The present invention also includes an apparatus for making the comestible units and the units themselves. The product prepared in accordance with the pres... | 04/22/1997 |
| 5612054 | Pharmaceutical compositions for treating gastrointestinal distress This invention relates to a pharmaceutical composition for treating gastrointestinal distress comprising an effective amount of an antidiarrheal composition, e.g. loperamide, and an antiflatulent effective amount of simethicone and methods of treating gas... | 03/18/1997 |
| 5560913 | Pharmaceutical compositions The present invention relates to orally ingestible, pharmaceutical compositions containing at least one pharmaceutical active and a taste masking component.... | 10/01/1996 |
| 5543153 | Antacid A solid effervescent antacid formulation comprising as primary ingredients from about 35 to about 53 percent by weight of calcium carbonate, from about 0 to about 14 percent by weight of magnesium carbonate, from about 3.5 to about 7 percent by weight of ... | 08/06/1996 |
| 5527548 | Food products containing benzimidazole A method for promoting digestibility of a food product having an acid character which, when ingested, causes stimulation and hypersecretion of gastric and/or duodenum mucosae. The method comprises incorporating into the food product a sufficient amount of... | 06/18/1996 |
| 5461082 | Dried aluminum hydroxide gel, a method for preparing the dried gel, and an antacid The object of the present invention is to prepare a dried aluminum hydroxide gel featuring excellent acid neutrizing capacity, but which is also stable. A dried aluminum hydroxide gel with a chemical composition represented by the following general formul... | 10/24/1995 |